Six months ago.
Proteomics International rescinds PromarkerD exclusive licence deal with PrismHealthDx in US – negotiations brought forward with new tier 1 partners.
Two months ago.
Proteomics International to use the BIO opportunity to meet with partners for their US roll-out as part of their global expansion of PromarkerD, which now includes Mexico and the EU.
Today
Proteomics International encouraged by interest from a range of global companies and tier 1 national diagnostic groups.
They have dropped any talk of tier 1 partners in the 4c. and now simply refer to them as tier 1 international groups.
Like Eqz, I look forward to the significant updates from Richard in the coming weeks, and significant they need to be.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)